The Fast Track for Intestinal Tumor Cell Differentiation and In Vitro Intestinal Models by Inorganic Topographic Surfaces

被引:4
|
作者
Centonze, Matteo [1 ]
Berenschot, Erwin J. W. [2 ]
Serrati, Simona [3 ]
Susarrey-Arce, Arturo [2 ]
Krol, Silke [1 ]
机构
[1] S de Bellis Res Hosp, Natl Inst Gastroenterol, Lab Personalized Med, Castellana Grotte Via Turi 27, I-70013 Bari, BA, Italy
[2] Univ Twente, MESA Inst, Mesoscale Chem Syst, POB 217, NL-7500 AE Enschede, Netherlands
[3] IRCCS Ist Tumori Giovanni Paolo II, Nanotechnol Lab, Viale Orazio Flacco 65, I-70124 Bari, BA, Italy
关键词
HT29; differentiation; lectins; topographic surfaces; Paneth cells; in vitro intestinal model; COLON-CARCINOMA-CELLS; LECTIN-BINDING; EPITHELIAL POLARITY; PANETH CELL; EXPRESSION; MUCUS; HT-29; GROWTH; TISSUE; MUCIN;
D O I
10.3390/pharmaceutics14010218
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Three-dimensional (3D) complex in vitro cell systems are well suited to providing meaningful and translatable results in drug screening, toxicity measurements, and biological studies. Reliable complex gastrointestinal in vitro models as a testbed for oral drug administration and toxicity are very valuable in achieving predictive results for clinical trials and reducing animal testing. However, producing these models is time-consuming due to the lengthy differentiation of HT29 or other cells into mucus-producing goblet cells or other intestinal cell lineages. In the present work, HT29 cells were grown on an inorganic topographic surface decorated with a periodic pattern of micrometre-sized amorphous SiO2 structures for up to 35 days. HT29 cells on topographic surfaces were compared to undifferentiated HT29 in glucose-containing medium on glass or culture dish and with HT29 cells differentiated for 30 days in the presence of methotrexate (HT29-MTX). The cells were stained with Alcian blue for mucus, antibodies for mucus 2 (goblet cells), villin (enterocytes), lysozyme (Paneth cells), and FITC-labeled lectins to identify different cells, glycomic profiles, and cell features. We observed that HT29 cells on topographic surfaces showed more similarities with the differentiated HT29-MTX than with undifferentiated HT29. They formed islands of cell clusters, as observed for HT29-MTX. Already after 2 days, the first mucus secretion was shown by Alcian blue stain and FITC-wheat germ agglutinin. After 4-6 days, mucus was observed on the cell surface and in the intercellular space. The cell layer was undulated, and in 3D reconstruction, the cells showed a clear polarisation with a strong actin signal to one membrane. The lectins and the antibody-staining confirmed the heterogeneous composition of differentiated HT29 cells on topographic surfaces after 6-8 days, or after 6-8 days following MTX differentiation (30 days).
引用
收藏
页数:12
相关论文
共 50 条
  • [21] In vitro models for processes involved in intestinal absorption
    Nigsch, Florian
    KJaffke, Werner
    Miret, Silvia
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2007, 3 (04) : 545 - 556
  • [22] Towards bioinspired in vitro models of intestinal mucus
    Sardelli, Lorenzo
    Pacheco, Daniela Peneda
    Ziccarelli, Anna
    Tunesi, Marta
    Caspani, Omar
    Fusari, Andrea
    Vangosa, Francesco Briatico
    Giordano, Carmen
    Petrini, Paola
    RSC ADVANCES, 2019, 9 (28) : 15887 - 15899
  • [23] In Vitro Intestinal and Liver Models for Toxicity Testing
    Orbach, Sophia M.
    Less, Rebekah R.
    Kothari, Anjaney
    Rajagopalan, Padmavathy
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2017, 3 (09): : 1898 - 1910
  • [24] Intestinal absorption of forsythoside A in in situ single-pass intestinal perfusion and in vitro Caco-2 cell models
    Zhou, Wei
    Di, Liu-qing
    Wang, Juan
    Shan, Jin-jun
    Liu, Shi-jia
    Ju, Wen-zheng
    Cai, Bao-chang
    ACTA PHARMACOLOGICA SINICA, 2012, 33 (08) : 1069 - 1079
  • [25] Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo
    Kubokura, Naoya
    Takahashi-Yanaga, Fumi
    Arioka, Masaki
    Yoshihara, Tatsuya
    Igawa, Kazunobu
    Tomooka, Katsuhiko
    Morimoto, Sachio
    Nakatsu, Yoshimichi
    Tsuzuki, Teruhisa
    Nakabeppu, Yusaku
    Matsumoto, Takayuki
    Kitazono, Takanari
    Sasaguri, Toshiyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 127 (04) : 446 - 455
  • [26] Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo
    Kubokura, Naoya
    Takahashi, Fumi
    Sasaguri, Toshiyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S123 - S123
  • [27] Combination of in vitro intestinal continuous fermentation and intestinal cell models to investigate Salmonella and probiotics interactions in infected gut microbiota
    Zihler, A.
    Gagnon, M.
    Chassard, C.
    Braegger, C. P.
    Lacroix, C.
    JOURNAL OF BIOTECHNOLOGY, 2010, 150 : S316 - S317
  • [28] Intestinal absorption of forsythoside A in in situ single-pass intestinal perfusion and in vitro Caco-2 cell models
    Wei Zhou
    Liu-qing Di
    Juan Wang
    Jin-jun Shan
    Shi-jia Liu
    Wen-zheng Ju
    Bao-chang Cai
    Acta Pharmacologica Sinica, 2012, 33 : 1069 - 1079
  • [29] MicroRNA Determines the Fate of Intestinal Epithelial Cell Differentiation and Regulates Intestinal Diseases
    Ding, Sujuan
    Liu, Gang
    Jiang, Hongmei
    Fang, Jun
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2019, 20 (07) : 666 - 673
  • [30] A comprehensive overview of advanced dynamic in vitro intestinal and hepatic cell culture models
    Leal, Filipa
    Zeiringer, Scarlett
    Jeitler, Ramona
    Costa, Pedro F. F.
    Roblegg, Eva
    TISSUE BARRIERS, 2024, 12 (01):